Published • loading... • Updated
MicroPort launches LBBOT Solution commercially in Europe and Australia
Summary by Medical Device Network
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Medical Device NetworkReposted by 
Verdict Hospital
Verdict HospitalMicroPort launches LBBOT Solution commercially in Europe and Australia
MicroPort CardioFlow has commercially launched its LBBOT Solution in Europe and Australia after obtaining the required regulatory approvals.The post MicroPort launches LBBOT Solution commercially in Europe and Australia appeared first on Medical Device Network.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
